Peer-reviewedCC BYBrain sciences
Long-Term Treatment Retention of Levetiracetam Monotherapy in Adults with Epilepsy: A 10-Year Retrospective Cohort Study Using Time-to-Treatment-Failure Analysis
- 1Department of Clinical Pharmacy, College of Pharmacy, , P.O. Box 70474, Riyadh 11567, Saudi Arabia; (W.H.A.); (S.A.A.); (A.A.A.)
- 2College of Medicine, , P.O. Box 70474, Riyadh 11567, Saudi Arabia;
Related
- Factors for Long-Term Ritodrine Monotherapy in the Treatment of Preterm Labor: A Single-Center Retrospective Study
- Infliximab Monotherapy as First-Line Treatment for Hepatic, Splenic, and Pulmonary Sarcoidosis in a Patient With High Cardiometabolic Risk.
- Third-generation EGFR-TKI plus pemetrexed-platinum chemotherapy versus TKI monotherapy as first-line treatment for EGFR-mutant lung adenocarcinoma with brain parenchymal metastases
- Fosfomycin monotherapy for the treatment of a complicated prostatic abscess caused by KPC-producing carbapenem-resistant Escherichia coli
- Toward Fairness in Machine Learning Models for Predicting Treatment Retention and Premature Discontinuation in Medication for Opioid Use Disorder
BibTeX
@article{alkathiri2026longterm,
title = {{Long-Term Treatment Retention of Levetiracetam Monotherapy in Adults with Epilepsy: A 10-Year Retrospective Cohort Study Using Time-to-Treatment-Failure Analysis}},
author = {Waad Hasan Alkathiri and Saeed Ali Alqahtani and Abdlatif Ahmed Alghaiheb and Bandar Nasser Aljafen and Bander Balkhi},
journal = {Brain sciences},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13702674},
note = {CC BY},
}
RIS
TY - JOUR
TI - Long-Term Treatment Retention of Levetiracetam Monotherapy in Adults with Epilepsy: A 10-Year Retrospective Cohort Study Using Time-to-Treatment-Failure Analysis
AU - Waad Hasan Alkathiri
AU - Saeed Ali Alqahtani
AU - Abdlatif Ahmed Alghaiheb
AU - Bandar Nasser Aljafen
AU - Bander Balkhi
PY - 2026
DA - 2026/10/01
JO - Brain sciences
UR - https://europepmc.org/article/PMC/PMC13702674
SN - 2076-3425
ER -